Fortress Biotech Reports Q2 2024 Financial Highlights
Fortress Biotech reveals Q2 2024 financials with key FDA updates; NDA and BLA filings signal growth in dermatology and oncology.
- Latest
- Trending
Fortress Biotech reveals Q2 2024 financials with key FDA updates; NDA and BLA filings signal growth in dermatology and oncology.
Memecoins like Floki, Dogwifhat, and Bonk defy market downturn with double-digit gains, highlighting their resilience amid broader crypto sell-offs.
Crypto Market Crash: Bitcoin drops below $63,000; major altcoins like Ethereum, Dogecoin, and Solana also see significant declines.
"Discover how VR and modified craniotomy techniques enhance brain surgery, improving MMA preservation rates and patient outcomes in MMD and ...
Eli Lilly's Zepbound reduces sleep apnea by up to 52% in trials, showing promise beyond weight loss. FDA approval for ...
Duane’s House of Pizza acquired by Slainte Hospitality, planning expansion near NDSU and other towns, maintaining quality and legacy.
Cyber hackers Qilin leak 400GB of NHS blood test data, including patient info and financial records, disrupting London hospitals and ...
Australia-based pharmaceuticals company CSL has reported a 17% increase in half-year net profit, driven by strong performance in its blood-plasma ...
Discover the warning about tissue contamination when using AI in medicine. AI struggles to accurately analyze samples due to real-world ...
Discover how surgeons are using real-time MRIs to enhance the safety and efficacy of gene therapy surgeries, revolutionizing the approach ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.